Tang Mitosis/Apoptosis ver. II - Dataset (ID:20003)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Assay compound conc (uM) | Day | Image | Cell count | Interphase count | Apoptotic count | Dead count | Mitotic count | % Interphase | % Apoptotic | % Mitotic | Recorded Plate | Recorded Well | Control Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MLN8054 | PE/CA-PJ15 | 0.00019 | 2 | | 1885 | 1802 | 22 | 0 | 61 | 95.60 | 1.17 | 3.24 | 6 | K12 | |
MLN8054 | PE/CA-PJ15 | 0.00019 | 3 | | 3473 | 3328 | 60 | 0 | 85 | 95.83 | 1.73 | 2.45 | 6 | K12 | |
Tozasertib | PE/CA-PJ15 | 0.137 | 1 | | 686 | 633 | 12 | 7 | 34 | 92.27 | 2.77 | 4.96 | 6 | K13 | |
Tozasertib | PE/CA-PJ15 | 0.137 | 2 | | 1071 | 1009 | 33 | 8 | 21 | 94.21 | 3.83 | 1.96 | 6 | K13 | |
Tozasertib | PE/CA-PJ15 | 0.137 | 3 | | 1039 | 945 | 83 | 0 | 11 | 90.95 | 7.99 | 1.06 | 6 | K13 | |
PE/CA-PJ15 | 1 | | 922 | 851 | 32 | 10 | 29 | 92.30 | 4.56 | 3.15 | 6 | K14 | N | ||
PE/CA-PJ15 | 2 | | 2023 | 1916 | 38 | 0 | 69 | 94.71 | 1.88 | 3.41 | 6 | K14 | N | ||
PE/CA-PJ15 | 3 | | 3283 | 3131 | 54 | 0 | 98 | 95.37 | 1.64 | 2.99 | 6 | K14 | N | ||
Tozasertib | PE/CA-PJ15 | 0.137 | 1 | | 693 | 646 | 15 | 2 | 30 | 93.22 | 2.45 | 4.33 | 6 | K15 | |
Tozasertib | PE/CA-PJ15 | 0.137 | 2 | | 951 | 894 | 28 | 14 | 15 | 94.01 | 4.42 | 1.58 | 6 | K15 | |
Tozasertib | PE/CA-PJ15 | 0.137 | 3 | | 1070 | 977 | 77 | 0 | 16 | 91.31 | 7.20 | 1.50 | 6 | K15 | |
GSK1070916 | PE/CA-PJ15 | 0.137 | 1 | | 614 | 573 | 15 | 5 | 21 | 93.32 | 3.26 | 3.42 | 6 | K16 | |
GSK1070916 | PE/CA-PJ15 | 0.137 | 2 | | 999 | 923 | 38 | 17 | 21 | 92.39 | 5.51 | 2.10 | 6 | K16 | |
GSK1070916 | PE/CA-PJ15 | 0.137 | 3 | | 927 | 823 | 90 | 2 | 12 | 88.78 | 9.92 | 1.29 | 6 | K16 | |
Tozasertib | PE/CA-PJ15 | 0.00019 | 1 | | 974 | 918 | 25 | 8 | 23 | 94.25 | 3.39 | 2.36 | 6 | K17 | |
Tozasertib | PE/CA-PJ15 | 0.00019 | 2 | | 1870 | 1777 | 46 | 0 | 47 | 95.03 | 2.46 | 2.51 | 6 | K17 | |
Tozasertib | PE/CA-PJ15 | 0.00019 | 3 | | 3421 | 3288 | 43 | 0 | 90 | 96.11 | 1.26 | 2.63 | 6 | K17 | |
GSK1070916 | PE/CA-PJ15 | 0.137 | 1 | | 681 | 638 | 19 | 4 | 20 | 93.69 | 3.38 | 2.94 | 6 | K18 | |
GSK1070916 | PE/CA-PJ15 | 0.137 | 2 | | 996 | 914 | 46 | 11 | 25 | 91.77 | 5.72 | 2.51 | 6 | K18 | |
GSK1070916 | PE/CA-PJ15 | 0.137 | 3 | | 991 | 889 | 85 | 2 | 15 | 89.71 | 8.78 | 1.51 | 6 | K18 | |
Tozasertib | PE/CA-PJ15 | 0.00019 | 1 | | 976 | 913 | 24 | 3 | 36 | 93.55 | 2.77 | 3.69 | 6 | K19 | |
Tozasertib | PE/CA-PJ15 | 0.00019 | 2 | | 1926 | 1837 | 39 | 0 | 50 | 95.38 | 2.02 | 2.60 | 6 | K19 | |
Tozasertib | PE/CA-PJ15 | 0.00019 | 3 | | 3175 | 3064 | 60 | 0 | 51 | 96.50 | 1.89 | 1.61 | 6 | K19 | |
GSK1070916 | PE/CA-PJ15 | 0.00019 | 1 | | 985 | 920 | 22 | 10 | 33 | 93.40 | 3.25 | 3.35 | 6 | K20 | |
GSK1070916 | PE/CA-PJ15 | 0.00019 | 2 | | 2134 | 2066 | 40 | 0 | 28 | 96.81 | 1.87 | 1.31 | 6 | K20 |